COVID-19 associated invasive candidiasis.
作者信息
Al-Hatmi Abdullah M S, Mohsin Jalila, Al-Huraizi Aisha, Khamis Faryal
机构信息
Ministry of Health, Directorate General of Health Services, Ibri, Oman; Centre of Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands; Foundation of Atlas of Clinical Fungi, Hilversum, Netherlands.
Department of Medical Microbiology, Royal Hospital, Muscat, Oman.
出版信息
J Infect. 2021 Feb;82(2):e45-e46. doi: 10.1016/j.jinf.2020.08.005. Epub 2020 Aug 7.
Abstract
摘要
相似文献
1
COVID-19 associated invasive candidiasis.
J Infect. 2021 Feb;82(2):e45-e46. doi: 10.1016/j.jinf.2020.08.005. Epub 2020 Aug 7.
2
Fatal invasive candidiasis in COVID-19 patient with severe bleeding and extensively drug-resistant Klebsiella enterobacter.
J Infect Dev Ctries. 2022 Jun 30;16(6):1025-1029. doi: 10.3855/jidc.16256.
3
Fungal co-infection in COVID-19 patients: Should we be concerned?
Rev Iberoam Micol. 2020 Apr-Jun;37(2):41-46. doi: 10.1016/j.riam.2020.07.001. Epub 2020 Sep 14.
4
Invasive Infections during a COVID-19 Case Surge.
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0114621. doi: 10.1128/AAC.01146-21. Epub 2021 Aug 2.
5
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. doi: 10.1093/cid/ciaa1728.
6
Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
S Afr Med J. 2020 Oct 6;110(11):1081-1085.
7
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
8
Invasive candidiasis.
Nat Rev Dis Primers. 2018 May 11;4:18027. doi: 10.1038/nrdp.2018.27.
9
Coinfection with SARS-CoV-2 and Influenza A Virus in a 32-Year-Old Man.
Am J Case Rep. 2020 Nov 14;21:e926092. doi: 10.12659/AJCR.926092.
10
[Dengue and SARS-CoV-2 coinfection in an HIV positive patient].
Medicina (B Aires). 2020;80 Suppl 6:94-96.
引用本文的文献
1
Identification and antifungal resistance profiling of in a tertiary hospital in Istanbul, Türkiye.
Ann Saudi Med. 2025 Jul-Aug;45(4):207-217. doi: 10.5144/0256-4947.2025.207. Epub 2025 Aug 7.
2
Epidemiology of Candidemia, Candiduria and Emerging Candidozyma (Candida) auris Across Gulf Cooperative Council Countries and Yemen in the Arabian Peninsula.
Mycoses. 2025 Jun;68(6):e70073. doi: 10.1111/myc.70073.
3
Diagnostic Challenges in Fungal Coinfections Associated With Global COVID-19.
Scientifica (Cairo). 2025 May 7;2025:6840605. doi: 10.1155/sci5/6840605. eCollection 2025.
4
Endogenous Endophthalmitis Associated With COVID-19: A Systematic Review on Its Incidence, Risk Factors, Causative Organisms, and Prognosis.
Cureus. 2024 Sep 30;16(9):e70523. doi: 10.7759/cureus.70523. eCollection 2024 Sep.
5
Health of Saudi Women in the Post-Pandemic Era: Incidence and Post COVID-19 and COVID-19-Vaccination.
Int J Womens Health. 2024 Oct 13;16:1687-1697. doi: 10.2147/IJWH.S472953. eCollection 2024.
6
In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in China.
J Fungi (Basel). 2024 May 31;10(6):397. doi: 10.3390/jof10060397.
7
Design, Synthesis and Evaluation of Antifungal Activity of Pyrazoleacetamide Derivatives.
Med Chem. 2024;20(10):957-968. doi: 10.2174/0115734064300961240417063246.
8
Outbreaks: Current Status and Future Perspectives.
Microorganisms. 2024 May 1;12(5):927. doi: 10.3390/microorganisms12050927.
9
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
10
Evaluation of some immunological markers in co-infection of COVID-19 with thrush candidiasis.
Rev Assoc Med Bras (1992). 2024 May 13;70(4):e20230845. doi: 10.1590/1806-9282.20230845. eCollection 2024.
本文引用的文献
1
Diagnosing COVID-19-associated pulmonary aspergillosis.
Lancet Microbe. 2020 Jun;1(2):e53-e55. doi: 10.1016/S2666-5247(20)30027-6. Epub 2020 May 10.
2
Co-infections: potentially lethal and unexplored in COVID-19.
Lancet Microbe. 2020 May;1(1):e11. doi: 10.1016/S2666-5247(20)30009-4. Epub 2020 Apr 24.
3
Co-infections in people with COVID-19: a systematic review and meta-analysis.
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
4
Opportunistic bacterial, viral and fungal infections of the lung.
Medicine (Abingdon). 2016 Jun;44(6):378-383. doi: 10.1016/j.mpmed.2016.03.015. Epub 2016 May 5.
5
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.
Clin Infect Dis. 2020 Jul 28;71(15):769-777. doi: 10.1093/cid/ciaa272.
6
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy.
Crit Care. 2016 May 27;20(1):125. doi: 10.1186/s13054-016-1313-6.
Zotero 插件